Salmeterol Xinafoate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Salmeterol Xinafoate
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

Vamsi labs Salmeterol Xinafoate

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Salmeterol Xinafoate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 20 USDMF, 16 CEP/COS, 1 JDMF, 11 EU WC, 14 NDC API, 29 Listed Suppliers, $ API Reference Price

41 API Suppliers
20 USDMF
16 CEP/COS
1 JDMF
11 EU WC
14 NDC API
29 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

11 Intermediate Suppliers

11 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

225 FDF Dossiers, 23 FDA Orange Book, 143 Europe, 12 Canada, 2 Australia, 22 South Africa, 23 Listed Dossiers

225 FDF Dossiers
23 FDA Orange Book
143 Europe
12 Canada
2 Australia
22 South Africa
23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH

POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH
POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH
POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH
POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH
AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH
AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH
AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH

RELATED EXCIPIENT COMPANIES

1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 BASF, 2 DFE Pharma, 17 Kerry, 2 Microlex e.U, 1 Pluviaendo, 1 Roquette, 2 Sigachi Industries

1 Faran Shimi Pharmaceutical
2 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
2 BASF
2 DFE Pharma
17 Kerry
2 Microlex e.U
1 Pluviaendo
1 Roquette
2 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

20 Fillers, Diluents & Binders, 6 Co-Processed Excipients, 6 Granulation, 6 Direct Compression, 1 Coating Systems & Additives, 1 Controlled & Modified Release, 1 Parenteral

20 Fillers, Diluents & Binders
6 Co-Processed Excipients
6 Granulation
6 Direct Compression
1 Coating Systems & Additives
1 Controlled & Modified Release
1 Parenteral

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 81 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
81 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 125 Finished Drug Prices, 5 Annual Reports

1 US Medicaid Prescriptions
125 Finished Drug Prices
5 Annual Reports

MARKET PLACE

4 APIs, 2 FDF Dossiers

4 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

247 US Patents, 4 US Exclusivities, 14 Health Canada Patents

247 US Patents
4 US Exclusivities
14 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 6 USP, 7 Others

3 EDQM
6 USP
7 Others

$ API Ref.Price (USD/KG) : 39,700 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 4TEVA PHARM

filter Product Reset all filters

4 All

01 4FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

filter Exclusivity Expiration Date Reset all filters

4 All

01 22024-07-09

02 22025-01-09

filter Exclusivity Code Reset all filters

4 All

01 2M-61

02 2PED

Inke Salmeterol Xinafoate

Product Main Page

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2025-01-09

Application Number

208799

Product Number

4

Exclusivity Details

01

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

BioAsia

Not Confirmed

TEVA PHARM

Israel

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2025-01-09

Application Number : 208799

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2025-01-09

Application Number

208799

Product Number

1

Exclusivity Details

02

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

BioAsia

Not Confirmed

TEVA PHARM

Israel

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2025-01-09

Application Number : 208799

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-61

Exclusivity Expiration Date

2024-07-09

Application Number

208799

Product Number

4

Exclusivity Details

03

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

BioAsia

Not Confirmed

TEVA PHARM

Israel

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : M-61

Exclusivity Expiration Date : 2024-07-09

Application Number : 208799

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TEVA PHARM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-61

Exclusivity Expiration Date

2024-07-09

Application Number

208799

Product Number

1

Exclusivity Details

04

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

The Generic Rx Session

Not Confirmed

TEVA PHARM

Israel

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Exclusivity Code : M-61

Exclusivity Expiration Date : 2024-07-09

Application Number : 208799

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!